Conditions: Esophageal Cancer Stage IIB; Esophageal Cancer Stage III
Interventions: Combination Product: Paclitaxel, Cisplatin Plus 5-FU (TCF); Radiation: radiochemotherapy
Sponsors: Tianjin Medical University Cancer Institute and Hospital; Shanghai Chest Hospital; Henan Cancer Hospital; The First Affiliated Hospital with Nanjing Medical University; First Affiliated Hospital of Chongqing Medical University; The First Affiliated Hospital of Anhui Medical University
Not yet recruiting
http://ift.tt/2kDbM7z
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου